Foghorn Therapeutics Inc.FHTXNASDAQ
Loading
Debt to Assets Over TimeNormalizing
Percentile Rank71
3Y CAGR+17.9%
5Y CAGR-8.3%
Studio
Year-over-Year Change

Debt-to-assets ratio

3Y CAGR
+17.9%/yr
vs -6.0%/yr prior
5Y CAGR
-8.3%/yr
Recent acceleration
Acceleration
+23.9pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive growthNormalizing
PeriodValueYoY Change
20250.21+59.3%
20240.13-17.1%
20230.16+23.9%
20220.13+13.4%
20210.11-65.0%
20200.32-56.9%
20190.74+355.9%
20180.16-